Targeting novel classes of tumour antigens in BRCA-deficient breast cancer to improve immunotherapy responses and overcome resistance

  • Dolcetti, Riccardo (Primary Chief Investigator (PCI))
  • Faridi, Pouya (Chief Investigator (CI))
  • Mazzieri, Roberta (Chief Investigator (CI))
  • Dawson, Sarah-Jane (Chief Investigator (CI))
  • Loi, Sherene (Chief Investigator (CI))
  • Lindeman, Geoffery (Chief Investigator (CI))

Project: Research

Project Details

StatusActive
Effective start/end date1/09/2331/08/26

Funding

  • National Breast Cancer Foundation: A$853,060.00

Keywords

  • Immunopeptidomics
  • Immunotherapy
  • Breast cancer